LLY241227C710000
- 87.64
- 0.000.00%
Eli Lilly and Co Newsroom
Express News | Eli Lilly and Co China responds to the capacity of Tirzepatide: factories are operating day and night to meet patient demand.
U.S. stock market close | The three major Indexes had mixed performances, with the Dow rising for five consecutive days; Drone Concept stocks surged, with SES jumping 100%; Apple continued to reach new highs, with its Market Cap approaching 4 trillion dol
After the Christmas holiday, trading is quiet. The S&P and Nasdaq briefly turned positive, with Apple reaching a new high and its Market Cap approaching 4 trillion dollars. Tesla fell by 1.8%, NVIDIA's decline narrowed, Broadcom rose over 2%, Drone concept stocks surged, the Chinese concept index rose by 0.9% at one point, Ideal Autos increased by more than 9%, and Kingsoft Cloud rose over 14%.
Novo-Nordisk A/S faces another blow: Musk shares a weight loss photo, claiming that using Eli Lilly and Co's weight loss drug is more effective than semaglutide.
On Christmas, Musk shared a photo and called himself the Ozempic Santa Claus, clarifying that he didn't mean the drug name Ozempic for semaglutide, but rather Eli Lilly and Co's competitor Mounjaro. He also mentioned that "high doses" of Ozempic would make him fart and burp, adding that "Mounjaro seems to have fewer side effects and is more effective."
Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
Musk revealed that he switched to using Eli Lilly and Co's weight loss medication: the effect is better than Novo-Nordisk A/S's competing products, with fewer side effects.
① The world's richest man, Elon Musk, confirmed on the Social Media platform X on Wednesday that he is using Eli Lilly and Co's Mounjaro for weight loss; ② Musk revealed that he initially tried using Novo-Nordisk A/S's Ozempic for weight loss but switched to Mounjaro due to significant side effects.
Jim Cramer Says Eli Lilly and Company (LLY)'s 'Going To Win'
Musk "endorses" Eli Lilly and Co (LLY.US) weight loss drug: Mounjaro has fewer side effects and better results.
On Wednesday, Musk posted on the X platform emphasizing that he prefers Eli Lilly and Co's product Mounjaro over Novo-Nordisk A/S's weight loss treatment Ozempic.
Elon Musk Says He Prefers Lilly's Mounjaro Over Novo's Ozempic
"Nuo Li" weight loss miracle drug mainstreaming brings new challenges in terms of applicability, medical insurance, and more.
GLP-1 is changing the way people view and treat obesity. These changes are happening so quickly that they may benefit many people, leading to new questions and ethical dilemmas for medical professionals, including who should receive medication treatment.
Express News | Eli Lilly and Co has launched a new drug for Alzheimer's disease: annual medication costs exceed 0.03 million dollars. Pfizer and Roche are making arrangements.
Eli Lilly and Co (LLY) Is Among Billionaire Coleman's Top Picks
Express News | Eli Lilly and Co's weight loss medication is now available for purchase on e-commerce platforms, and Eli Lilly and Co China responded that it is a self-pay medication.
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
Weight-loss Drugs in 2025, Auto Industry Outlook: Market Domination
Eli Lilly's Weight Loss Med Tirzepatide Gets Endorsement From U.K.'s NICE
With EPS Growth And More, Eli Lilly (NYSE:LLY) Makes An Interesting Case
Eli Lilly's Anti-Obesity Drug Mounjaro to Be Supported by UK Public Health System for Some Patients
The USA FDA has revoked the emergency use authorization for four COVID-19 antibody drugs.
On December 24, Gelonghui reported that the USA Food and Drug Administration (FDA) has revoked the emergency use authorization for four COVID-19 antibody drugs, including Eli Lilly and Co's bebtelovimab, AstraZeneca's Evusheld, GlaxoSmithKline's sotrovimab, and Regeneron's REGEN-COV. The FDA stated in a letter earlier this month that the shelf life of these drugs has expired, and due to the spread of non-susceptible variants, they have not been authorized for patient use for more than a year. According to the FDA, the four companies mentioned above do not intend to continue providing the relevant products in the USA and will notify customers and suppliers.
U.S. stocks closed higher | The three major Indexes collectively rose, with the Nasdaq increasing by nearly 1%; chip stocks surged, with Broadcom and Taiwan Semiconductor rising over 5%, and NVIDIA increasing nearly 4%.
① The Nasdaq China Golden Dragon Index rose by 0.91%; ② The PHLX Semiconductor Index rose by over 3%; ③ MicroStrategy purchased 5,262 Bitcoins; ④ The suspect in the UnitedHealth executive's murder case pleaded not guilty.
Sector Update: Health Care Stocks Advance Late Afternoon